Irvine, CA, United States of America

Kwok-Yin Tsang


Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Kwok-Yin Tsang

Introduction

Kwok-Yin Tsang is a notable inventor based in Irvine, CA, who has made significant contributions to the field of pharmaceuticals. He holds a total of 3 patents that focus on innovative methods for treating retinoid responsive disorders. His work is particularly relevant in the context of developing targeted therapies that enhance treatment efficacy.

Latest Patents

One of his latest patents is titled "Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B." This invention provides methods for treating individuals with retinoid responsive disorders by administering selective inhibitors that target CYP26B or CYP26A. The selective CYP26B inhibitor demonstrates at least 10-fold selectivity for CYP26B relative to CYP26A, showcasing a tailored approach to treatment. Another significant patent involves "4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity." This patent describes compounds that exhibit inhibitory activity against cytochrome P450RAI-1 and P450RAI-2, which are suitable for treating conditions responsive to retinoids.

Career Highlights

Kwok-Yin Tsang is currently associated with Allergan, Inc., a company renowned for its focus on innovative pharmaceuticals. His work at Allergan has allowed him to contribute to advancements in medical treatments, particularly in the area of retinoid therapies.

Collaborations

He has collaborated with notable colleagues such as Jayasree Vasudevan and Liming Wang, enhancing the research and development efforts within his field.

Conclusion

Kwok-Yin Tsang's innovative patents and contributions to the pharmaceutical industry highlight his commitment to advancing medical treatments for retinoid responsive disorders. His work continues to pave the way for more effective therapies in this important area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…